INTERNATIONAL PATENT: LG CHEM, LTD., 주식회사 엘지화학 FILES APPLICATION FOR "NOVEL COMPOUND USED AS CBP/PA300 INHIBITOR AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, INFLAMMATORY DISORDERS, OR AUTOIMMUNE DISEASES COMPRISING SAME AS ACTIVE INGREDIENT"

GENEVA, July 30 -- LG CHEM, LTD. (128 Yeoui-daero,Yeongdeungpo-Gu,Seoul 07336), 주식회사 엘지화학 (서울특별시영등포구여의대로 128) filed a patent application (PCT/KR2025/099053) for "NOVEL COMPOUND USED AS CBP/PA300 INHIBITOR, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, INFLAMMATORY DISORDERS, OR AUTOIMMUNE DISEASES COMPRISING SAME AS ACTIVE INGREDIENT" on Jan 16, 2025. With publication no. WO/2025/155165, the details related to the patent application was published on Jul 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is...